Technology Landscape, Trends and Opportunities in the Global Stent Market
Get it in 2 to 4 weeks by ordering today
The technologies in stent have undergone significant change in recent years, with bare metal coronary stents t%li%bioabsorbable stents. The rising wave of new technologies such as drug-eluting stents (DES) and bioabsorbable stents technology are creating significant potential for advanced stent implants in various medical platforms due t%li%increasing adoption of minimally invasive techniques.
In stent market, various technologies such as drug-eluting stents (DES), bare-metal coronary stents, and bioabsorbable stents, iliac stents, femoral-popliteal stents, renal and related stents, and carotid stents are used in the coronary and peripheral vascular applications. Increasing adoption of minimally invasive techniques, rising number of cardiovascular surgeries, and hectic lifestyle coupled with rising geriatric population base are creating opportunities for various stent technologies.
This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the stent market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global stent technology by application, technology, and region as follows:
Technology Readiness by Technology Type
Competitive Intensity and Regulatory Compliance
Disruption Potential by Technology Type
Trends and Forecasts by Technology Type [$M shipment analysis from 2018 t%li%2030]:
Companies / Ecosystems
Strategic Opportunities by Technology Type
Some of the stent companies profiled in this report include Terum%li%Corporation, Stentys, Microport Scientific Corporation, Medtronic, Elixir Medical Corporation, C. R. Bard, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen, and Abbott Laboratories.
This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the stent market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in stent market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats t%li%these technologies in stent market?
Q.6 What are the latest developments in stent technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Wh%li%are the major players in this stent market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this stent technology space?
The technologies in stent have undergone significant change in recent years, with bare metal coronary stents t%li%bioabsorbable stents. The rising wave of new technologies such as drug-eluting stents (DES) and bioabsorbable stents technology are creating significant potential for advanced stent implants in various medical platforms due t%li%increasing adoption of minimally invasive techniques.
In stent market, various technologies such as drug-eluting stents (DES), bare-metal coronary stents, and bioabsorbable stents, iliac stents, femoral-popliteal stents, renal and related stents, and carotid stents are used in the coronary and peripheral vascular applications. Increasing adoption of minimally invasive techniques, rising number of cardiovascular surgeries, and hectic lifestyle coupled with rising geriatric population base are creating opportunities for various stent technologies.
This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the stent market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global stent technology by application, technology, and region as follows:
Technology Readiness by Technology Type
Competitive Intensity and Regulatory Compliance
Disruption Potential by Technology Type
Trends and Forecasts by Technology Type [$M shipment analysis from 2018 t%li%2030]:
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
- Iliac Stents
- Femoral-Popliteal Stents
- Renal and Related Stents
- Carotid Stents
- Coronary
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
- Peripheral Vascular
- Iliac Stents
- Femoral-Popliteal Stents
- Renal and Related Stents
- Carotid Stents
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Companies / Ecosystems
Strategic Opportunities by Technology Type
Some of the stent companies profiled in this report include Terum%li%Corporation, Stentys, Microport Scientific Corporation, Medtronic, Elixir Medical Corporation, C. R. Bard, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen, and Abbott Laboratories.
This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the stent market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in stent market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats t%li%these technologies in stent market?
Q.6 What are the latest developments in stent technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Wh%li%are the major players in this stent market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this stent technology space?
1. EXECUTIVE SUMMARY
2. TECHNOLOGY LANDSCAPE
2.1. Technology Background and Evolution
2.2. Technology and Application Mapping
2.3. Supply Chain
3. TECHNOLOGY READINESS
3.1. Technology Commercialization and Readiness
3.2. Drivers and Challenges in Stent Technologies
3.3. Competitive Intensity
3.4. Regulatory Compliance
4. TECHNOLOGY TRENDS AND FORECASTS ANALYSIS FROM 2018-2030
4.1. Stent Opportunity
4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
4.2.1. Drug-Eluting Stents (DES)
4.2.2. Bare-Metal Coronary Stents
4.2.3. Bioabsorbable Stents
4.2.4. Iliac Stents
4.2.5. Femoral-Popliteal Stents
4.2.6. Renal and Related Stents
4.2.7. Carotid Stents
4.3. Technology Trends (2018-2023) and Forecasts (2024-2030) by Application Segments
4.3.1. Coronary Stent
4.3.1.1. Drug-Eluting Stents (DES)
4.3.1.2. Bare-Metal Coronary Stents
4.3.1.3. Bioabsorbable Stents
4.3.2. Peripheral Vascular
4.3.2.1. Iliac Stents
4.3.2.2. Femoral-Popliteal Stents
4.3.2.3. Renal and Related Stents
4.3.2.4. Carotid Stents
5. TECHNOLOGY OPPORTUNITIES (2018-2030) BY REGION
5.1. Stent Market by Region
5.2. North American Stent Technology Market
5.2.1. United States Stent Technology Market
5.2.2. Canadian Stent Technology Market
5.2.3. Mexican Stent Technology Market
5.3. European Stent Technology Market
5.3.1. The United Kingdom Stent Technology Market
5.3.2. German Automotive Stent Technology Market
5.3.3. French Automotive Stent Technology Market
5.4. APAC Stent Technology Market
5.4.1. Chinese Stent System Technology Market
5.4.2. Japanese Stent System Technology Market
5.4.3. Indian Stent System Technology Market
5.4.4. South Korean Stent Technology Market
5.5. ROW Stent Technology Market
6. LATEST DEVELOPMENTS AND INNOVATIONS IN THE STENT TECHNOLOGIES
7. COMPANIES / ECOSYSTEM
7.1. Product Portfolio Analysis
7.2. Market Share Analysis
7.3. Geographical Reach
8. STRATEGIC IMPLICATIONS
8.1. Implications
8.2. Growth Opportunity Analysis
8.2.1. Growth Opportunities for the Stent Market by Technology Type
8.2.2. Growth Opportunities for the Stent Market by Application
8.2.3. Growth Opportunities for the Stent Market by Region
8.3. Emerging Trends in the Stent Market
8.4. Disruption Potential
8.5. Strategic Analysis
8.5.1. New Product Development
8.5.2. Capacity Expansion of the Stent Market
8.5.3. Mergers, Acquisitions, and Joint Ventures in the Stent Market
9. COMPANY PROFILES OF LEADING PLAYERS
9.1. Terumo Corporation
9.2. Stentys
9.3. Microport Scientific Corporation
9.4. Medtronic
9.5. Elixir Medical Corporation
9.6. C. R. Bard
9.7. Boston Scientific Corporation
9.8. Biotronik SE & Co. KG
9.9. B. Braun Melsungen
9.10. Abbott Laboratories
2. TECHNOLOGY LANDSCAPE
2.1. Technology Background and Evolution
2.2. Technology and Application Mapping
2.3. Supply Chain
3. TECHNOLOGY READINESS
3.1. Technology Commercialization and Readiness
3.2. Drivers and Challenges in Stent Technologies
3.3. Competitive Intensity
3.4. Regulatory Compliance
4. TECHNOLOGY TRENDS AND FORECASTS ANALYSIS FROM 2018-2030
4.1. Stent Opportunity
4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
4.2.1. Drug-Eluting Stents (DES)
4.2.2. Bare-Metal Coronary Stents
4.2.3. Bioabsorbable Stents
4.2.4. Iliac Stents
4.2.5. Femoral-Popliteal Stents
4.2.6. Renal and Related Stents
4.2.7. Carotid Stents
4.3. Technology Trends (2018-2023) and Forecasts (2024-2030) by Application Segments
4.3.1. Coronary Stent
4.3.1.1. Drug-Eluting Stents (DES)
4.3.1.2. Bare-Metal Coronary Stents
4.3.1.3. Bioabsorbable Stents
4.3.2. Peripheral Vascular
4.3.2.1. Iliac Stents
4.3.2.2. Femoral-Popliteal Stents
4.3.2.3. Renal and Related Stents
4.3.2.4. Carotid Stents
5. TECHNOLOGY OPPORTUNITIES (2018-2030) BY REGION
5.1. Stent Market by Region
5.2. North American Stent Technology Market
5.2.1. United States Stent Technology Market
5.2.2. Canadian Stent Technology Market
5.2.3. Mexican Stent Technology Market
5.3. European Stent Technology Market
5.3.1. The United Kingdom Stent Technology Market
5.3.2. German Automotive Stent Technology Market
5.3.3. French Automotive Stent Technology Market
5.4. APAC Stent Technology Market
5.4.1. Chinese Stent System Technology Market
5.4.2. Japanese Stent System Technology Market
5.4.3. Indian Stent System Technology Market
5.4.4. South Korean Stent Technology Market
5.5. ROW Stent Technology Market
6. LATEST DEVELOPMENTS AND INNOVATIONS IN THE STENT TECHNOLOGIES
7. COMPANIES / ECOSYSTEM
7.1. Product Portfolio Analysis
7.2. Market Share Analysis
7.3. Geographical Reach
8. STRATEGIC IMPLICATIONS
8.1. Implications
8.2. Growth Opportunity Analysis
8.2.1. Growth Opportunities for the Stent Market by Technology Type
8.2.2. Growth Opportunities for the Stent Market by Application
8.2.3. Growth Opportunities for the Stent Market by Region
8.3. Emerging Trends in the Stent Market
8.4. Disruption Potential
8.5. Strategic Analysis
8.5.1. New Product Development
8.5.2. Capacity Expansion of the Stent Market
8.5.3. Mergers, Acquisitions, and Joint Ventures in the Stent Market
9. COMPANY PROFILES OF LEADING PLAYERS
9.1. Terumo Corporation
9.2. Stentys
9.3. Microport Scientific Corporation
9.4. Medtronic
9.5. Elixir Medical Corporation
9.6. C. R. Bard
9.7. Boston Scientific Corporation
9.8. Biotronik SE & Co. KG
9.9. B. Braun Melsungen
9.10. Abbott Laboratories
